Skip to main content
SpringerLink
Log in

The lack of transparency regarding the phosphate content of drugs

  • Letter to the Editor
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008;35(2):329–44.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ikizler TA, Borrowes JD, Byham-Gray LD, et al. KDOQI clinical practice guideline for nutrition in CKD. AJKD. 2020;76(3):1–107.

    Article  CAS  PubMed  Google Scholar 

  3. Sherman RA, Ravella S, Kapoian T. A dearth of data: the problem of phosphorus in prescription medications. Kidney Int. 2015;87(6):1097–9.

    Article  CAS  PubMed  Google Scholar 

  4. Nelson SM, Sarabia SR, Christilaw E, et al. Phosphate-containing prescription medications contribute to the daily phosphate intake in a third of hemodialysis patients. J Ren Nutr. 2017;27(2):91–6.

    Article  CAS  PubMed  Google Scholar 

  5. Sawin DA, Ma L, Stennett A, et al. Phosphates in medications: impact on dialysis patients. Clin Nephrol. 2020;93(4):163–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank the companies that responded to our inquiry Donna Lykke Wolff for contributing statistical analysis and Caroline Margaret Moos for proofreading.

Funding

No funding was received.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University Hospital of Southern Jutland, Sydvang 1, 6400, Sønderborg, Denmark

    Kenneth Maersk Christensen & Jan Dominik Kampmann

  2. Department of Emergency Medicine, University Hospital of Southern Denmark, Kresten Philipsens Vej 15, 6200, Aabenraa, Denmark

    Helene Skjøt-Arkil

  3. Hospital Pharmacy Research Unit, University Hospital of Southern Denmark, Kresten Philipsens Vej 15, 6200, Aabenraa, Denmark

    Lene Juel Kjeldsen

  4. Department of Regional Health Research, University of Southern Denmark, Campusvej 55, 5230, Odense, Denmark

    Helene Skjøt-Arkil, Lene Juel Kjeldsen & Jan Dominik Kampmann

Authors
  1. Kenneth Maersk Christensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helene Skjøt-Arkil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lene Juel Kjeldsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan Dominik Kampmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Dominik Kampmann.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Christensen, K.M., Skjøt-Arkil, H., Kjeldsen, L.J. et al. The lack of transparency regarding the phosphate content of drugs. Int J Clin Pharm 45, 1019–1021 (2023). https://doi.org/10.1007/s11096-023-01594-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-023-01594-w

Search

Navigation